ZymoGenetics/Serono Will Start Lupus Trials For TACI-Ig In 2nd Half Of 2003
Executive Summary
ZymoGenetics will initiate clinical studies for its autoimmune disease agent TACI-Ig in systemic lupus erythematosis during the second half of 2003, the company said during its Dec. 3 analyst presentation in New York